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INTRODUCTION:  Pancreatic  neuroendocrine  tumors  (PNET)  are  rare,  often  indolent  malignancies.  PNET  are
classiﬁed  as  functional  or  nonfunctional  based  on the  secretion  of  hormones  without  a negative  feedback
loop;  the  latter  account  for  up  to  60%  of PNET.  Although  PNET  are  associated  with  a better  prognosis
compared  to pancreatic  adenocarcinomas,  they  are  often  diagnosed  in  advanced  stages,  making  them
a  signiﬁcant  source  of morbidity  for patients.  Here  we  present  a rare case  of venous  tumor  thrombus
arising  from  a nonfunctional  PNET.
PRESENTATION  OF  CASE:  A 44-year-old  woman  was  referred for  evaluation  and  treatment  of a  possible  tail
of pancreas  PNET  discovered  during  work-up  for a 9 year  history  of intermittent  subcostal  pain.  Previous
endoscopic  ultrasound  with  ﬁne  needle  aspiration  revealed  a 3.5  cm  ×  3  cm mass,  with  cytological  diag-
nosis  of neuroendocrine  tumor.  Patient  was  scheduled  for laparoscopic  distal  pancreatectomy.  During
surgery  the  mass  was found  to encase  the  splenic  vein  leading  the  surgeon  to  perform  an  en  bloc  distal
pancreatectomy  and  splenectomy.  Pathologic  analysis  revealed  a 1.8 cm  ×  5 cm  tumor  thrombus  lodged
in  the  splenic  vein.
DISCUSSION: Nonfunctional  PNET  usually  present  in  advanced  stages  and  can be  associated  with  venous
tumor  thrombi.  Preoperative  imaging  may  not  accurately  predict  the  presence  of venous  tumor  thrombi.
CONCLUSION:  En bloc  resection  of  primary  tumor,  involved  organs  and  thrombus  is the  recommended
treatment  option  and  often  results  in  long  term  survival.  New  multi-modality  strategies  are  needed  for
detection of  venous  involvement  in  nonfunctional  PNET  to better  assist  with  preoperative  planning  and
counseling.
© 2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Pancreatic neuroendocrine tumors (PNETs) are rare and often
ndolent malignancies with an incidence lower than 1 per 100,000
ersons per year. These tumors account for only 1–3% of diagnosed
ancreatic neoplasms.1 Although PNETs are generally associated
ith a better prognosis compared to pancreatic adenocarcinomas,
any PNETs are diagnosed in advanced stages, making them a sig-
iﬁcant source of morbidity for patients with this disease.1
Derived from cells of the endocrine pancreas, some of these
umors are able to secrete gut hormones without a normal nega-
ive feedback loop. These secreting tumors are known as functional
NETs. However, up to 60% of all PNETs do not produce any mea-
ureable hormones; thus rendering them as nonfunctional PNETs
NF PNETs). Functional PNETs are more likely to be smaller in size
nd symptomatic earlier in their course as opposed to NF PNETs.
∗ Corresponding author at: 1201 Camino de Salud, NE, Albuquerque, NM 87131-
001, USA. Tel.: +1 505 925 0495.
E-mail address: KMorris@salud.unm.edu (K.T. Morris).
ttp://dx.doi.org/10.1016/j.ijscr.2014.11.045
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Nonfunctional PNETs lead to symptoms only when their size is large
enough to create a mass effect or when they invade into adjacent
or distant organs. When these tumors are found at earlier stages
they are generally an incidental ﬁnding noted on imaging done for
another purpose such as trauma. One rarely reported feature of
NF PNETs is the presence of venous tumor thrombus, which differs
from the venous occlusion more commonly seen in other pancreatic
malignancies, such as pancreatic adenocarcinoma.2–4
We present a rare case of venous tumor thrombus arising from
a NF PNET.
2. Case
A 44-year-old woman was  referred to our surgical oncology
department for evaluation and treatment of a possible PNET in
the tail of the pancreas. The patient had reported a 9 year his-
tory of intermittent left subcostal pain which radiated to the mid
epigastrium, left ﬂank and back. This pain was associated with
nausea, vomiting and diarrhea. The intermittent pain was exacer-
bated by drinking alcoholic beverages and, when severe, required
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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mig. 1. (A, B) Late arterial phase CT image demonstrating beginning of splenic vein 
B,  red arrow).
dmission and IV narcotics. No cross sectional imaging was per-
ormed during those encounters until six months before referral,
hen she developed pancreatitis. During her evaluation for this
 CT was performed which reported splenic vein occlusion at the
evel of the mid  body of the pancreas, and a 17 mm mildly enhanc-
ng mass within the tail of the pancreas (Fig. 1). After her symptoms
mproved, she was discharged and not seen by physicians until 3
onths later when she presented with a similar episode. At that
ime her referring physicians requested an endoscopic ultrasound
EUS). The EUS revealed a solid pancreatic tail mass measuring
.5 × 3 cm that was biopsied via ultrasound guided ﬁne needle
spiration. Histology revealed a low-grade neuroendocrine tumor
hich was staged uT2 N0 Mx  leading to her referral to our surgical
ncology team.
The patient’s past medical history was signiﬁcant for hypothy-
oidism and diverticulosis. Her past surgical history was  positive
or laparoscopic cholecystectomy, incisional hernia repair and hys-
erectomy/bilateral salpingo-oophorectomy secondary to uterine
upture at birth of her youngest child. Family history was  notable
or one aunt, one uncle and 2 cousins with diagnosis of pancreatic
denocarcinoma, all on the paternal side.Upon presentation she had mild hypertension, but an otherwise
ormal physical exam. Laboratory values were also within nor-
al  limits. Due to the cytology results conﬁrming PNET she was
Fig. 2. (A, B) Gross photograph of a tan lobulated ma thrombus (A, white arrow), and indistinct, mildly enhancing pancreatic tail lesion
scheduled for a laparoscopic distal pancreatectomy and possible
splenectomy. She received preoperative immunizations and then
underwent surgery.
An initial laparoscopic approach was performed with conver-
sion to a midline open laparotomy due to poor visualization of the
distal pancreas secondary to adhesions. The pancreas was found
to be soft with exception of the distal pancreatic tail where a ﬁrm
nodular mass was felt. The mass was found to encase the splenic
vein, so an en bloc distal pancreatectomy and splenectomy was
performed without complications. Frozen section of the proximal
margin of the pancreas was performed and shown to be negative
for tumor.
Pathology evaluation revealed a 3.3 cm × 2.2 cm × 2.8 cm tumor
within the distal pancreas (Fig. 2). Tumor was well circumscribed
and solid with a tan lobulated cut surface. The spleen was unre-
markable; the splenic vein, however, had a large tumor thrombus
which grossly protruded on gross sectioning (Fig. 3). The thrombus
measured 1.8 cm in diameter and extended approximately 5 cm
in length. Histological evaluation revealed an intermediate grade
PNET with surrounding fat necrosis (Fig. 4A). Immunohistochem-
istry staining for synaptophysin supported the diagnosis of PNET
(Fig. 4B). Peri-neural and vascular invasion were identiﬁed. None of
the 5 examined lymph nodes were positive for metastasis, leading
to a pathological tumor stage of T2 N0 M0.
ss (arrows) within the pancreatic parenchyma.
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To our knowledge, this is one of the few reported cases of
F
sig. 3. Gross photograph of tumor thrombus (black arrow) protruding from the
plenic vein.
. Discussion
We  present a case of a NF PNET with an associated splenic vein
umor thrombus. Although the incidence of PNETs has increased in
he last 2 decades, they continue to be a rarely diagnosed malig-
ancy of the pancreas.5,6 While PNETs account for only 1–3% of all
iagnosed pancreatic malignancies, in more recent autopsy stud-
es, their incidence reaches up to 10%, suggesting that these tumors
requently go unnoticed.1
Splenic vein tumor thrombosis arising from PNETs has rarely
een described in the literature. Bok and colleagues reported
hat from 76 patients evaluated by angiogram only one (1%) had
plenic vein occlusion; unfortunately, the cause of this occlusion
hether standard venous thrombosis vs tumor thrombosis was
ot reported.3 A larger cohort of patients reviewed by Balachan-
ran and associates found that out of the 88 patients examined,
9 (33%) had evidence of venous tumor thrombus on computed
omography images. Of these, 15 (52%) were located in the splenic
ein. Only one tumor thrombus in the splenic vein was conﬁrmed
ig. 4. (A) Hematoxylin and eosin stain at 40× demonstrating intermediate grade pancrea
ynaptophysin staining.PEN  ACCESS
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pathologically; leading the authors to conclude, in accordance with
other investigators, that venous tumor thrombi were not accurately
reported on preoperative imaging.2,3
While the prognostic importance of splenic vein tumor throm-
bus is still to be completely understood due to its rarity,
complications and changes in surgical outcomes have been
reported. Splenic vein tumor thrombi arising from PNETs may
lead to sinistral hypertension or even pre-sinusoidal portal hyper-
tension if left untreated. The risk of having gastric varices and
upper gastrointestinal bleed is increased in patients with sinis-
tral hypertension; thus, increasing both morbidity and mortality of
PNETs.10,11 The low incidence of PNETs and even lower incidence
of associated splenic vein tumor thrombus, limits the possibility
of prospective randomized trials to deﬁne differences in surgical
treatment outcomes. In a comparison of patients with pancre-
atic adenocarcinoma who underwent distal pancreatectomy and
splenectomy, Dedania and colleagues found that those who had a
splenic vein thrombus were more likely to have pancreas-speciﬁc
complications including pancreatic ﬁstulas and delayed gastric
emptying; the median survival, however, was not signiﬁcantly
different compared to patients who  did not have a splenic vein
thrombus.12
Surgical intervention for PNETs continues to be the recom-
mended treatment,7 leading to a 10 year overall survival rate
of 60% and a disease free survival rate of 30%.4 The beneﬁts of
surgical intervention persist regardless of PNET subtype, signiﬁ-
cantly prolonging the survival of patients whose primary tumor is
removed.8 Distal pancreatectomy and splenectomy continue to be
the standard of care for tumors arising from the body and tail of the
pancreas and for those which present with invasion to the splenic
vein.7,9
Current literature on splenic vein tumor thrombus arising from
a PNET is scarce, and the majority of previously reported cases of
venous tumor thrombus from PNETs noted thrombus in the portal
vein.13–17 Ait-Ali and colleagues reported a case of a PNET directly
invading the splenic artery and vein; however, in contrast to this
case, the patient had signs of isolated left-sided portal hypertension
with gastric varices and there was  no mention of a venous tumor
thrombus in the splenic vessels.18splenic vein tumor thrombus arising from a PNET, and possibly
the ﬁrst case report of a splenic vein tumor thrombus without
invasion to adjacent organs or signs of sinistral hypertension. The
tic neuroendocrine tumor. (B) Immunohistochemistry stain with diffusely positive
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rst reported case of a splenic vein tumor thrombi arising from
 PNET was published in 1992, in which Watase and colleagues
eported a 16 cm × 13 cm × 12 cm PNET that directly invaded the
pleen, stomach, left kidney and left colic ﬂexure and was asso-
iated with left-sided portal hypertension.17 Other reported cases
f a PNET invading into the splenic vein also document the patient
resenting with sinistral hypertension, gastric varices and gastroin-
estinal bleeding.10,11
In summary, we note that preoperative cross-sectional imag-
ng may  not always predict venous tumor thrombus arising from
NETs. Recommend treatment for patients with PNETs should be
n bloc resection of tumor and thrombus with any other involved
rgans.
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